Silphium Asset Management’s Quest Diagnostics DGX Stock Holding History

Silphium Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$339K	Buy	+4,000	New	+$336K	0.39%	27

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Silphium Asset Management's DGX Position: Q3 2016 in Review

Silphium Asset Management opened a new position in Quest Diagnostics (DGX) in Q3 2016: 4,000 shares worth $339K. The stake represents 0.39% of the portfolio and ranks #27 among its holdings.

559 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

Silphium Asset Management held 4,000 shares of Quest Diagnostics worth $339K as of Q3 2016.
Quest Diagnostics was a new Silphium Asset Management position in Q3 2016.
Quest Diagnostics made up 0.39% of Silphium Asset Management's portfolio in Q3 2016, its #27 holding.
559 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Silphium Asset Management's 13F filing for Q3 2016, filed 30 Jan 2025.